Top compounds associated with response to MYO15B

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	navitoclax:piperlongumine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.16	1e-05
mRNA	Sorafenib	CCLE	pan-cancer	AAC	0.22	2e-05
mRNA	ABT-263	CTRPv2	pan-cancer	AAC	0.16	2e-05
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.16	2e-05
mRNA	Crizotinib	CTRPv2	pan-cancer	AAC	0.14	2e-05
mRNA	cabozantinib	CTRPv2	pan-cancer	AAC	0.16	3e-05
mRNA	niclosamide	CTRPv2	pan-cancer	AAC	-0.16	3e-05
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.15	6e-05
mRNA	ABT-737	CTRPv2	pan-cancer	AAC	0.15	6e-05
mRNA	BRD-K14844214	CTRPv2	pan-cancer	AAC	0.16	7e-05

Download CSV